Related Experiment Video
Updated: May 29, 2026

Analyzing Murine Schwann Cell Development Along Growing Axons
Published on: November 21, 2012
Insulin-like growth factor-binding protein-1 (IGFBP-1) regulates human schwannoma proliferation, adhesion and
1Clinical Neurobiology, Peninsula College for Medicine and Dentistry, Plymouth, UK.
Abstract:
Merlin is a tumour suppressor involved in the development of a variety of tumours including mesotheliomas. Neurofibromatosis type 2 (NF2), a dominantly inherited tumour disease, is also caused by loss of merlin. NF2 patients suffer from multiple genetically well-defined tumours, schwannomas are most frequent among those. Using our in vitro model for human schwannoma, we found that schwannoma cells display enhanced proliferation because of the overexpression/activation of platelet-derived growth factor receptor and ErbB2/3, increased cell-matrix adhesion because of the overexpression of integrins, and decreased apoptosis. Mechanisms underlying schwannomas basal proliferation and cell-matrix adhesion are not understood. Here, we investigated insulin-like growth factor-binding protein-1 (IGFBP-1), which is expressed and released from central nervous system tumours and strongly overexpressed in schwannoma at the mRNA level. IGFBP-1 acts via β1-integrin and focal-adhesion-kinase (FAK), which are strongly overexpressed and basally activated in schwannoma. Using short hairpin RNA knockdown, small inhibitors and recombinant IGFBP-1, we demonstrate that schwannoma cells, in contrast to Schwann cells, release IGFBP-1 that activates the Src/FAK pathway, via integrin β1, potentiating schwannoma's proliferation and cell-matrix adhesion. We show that FAK localizes to the nucleus and Src triggers IGFBP-1 production. Further, we observed downregulation of the tumour-suppressor phosphatase and tensin homolog in schwannoma cells leading to increased activity of anti-apoptotic AKT. Thus, IGFBP-1/integrin β1/Src/FAK pathway has a crucial role in merlin-related tumourigenesis and therefore represents an important therapeutic target in the treatment of merlin-deficient tumours.
Insights
Loss of merlin causes Neurofibromatosis type 2 (NF2) tumors like schwannomas. Researchers found that insulin-like growth factor-binding protein-1 (IGFBP-1) activates pathways that increase schwannoma cell growth and adhesion, offering a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Merlin is a tumor suppressor crucial for preventing mesotheliomas and Neurofibromatosis type 2 (NF2).
- Loss of merlin function leads to NF2, characterized by tumors like schwannomas, with poorly understood mechanisms of proliferation and adhesion.
- Schwannoma cells exhibit increased proliferation, cell-matrix adhesion, and reduced apoptosis due to factors like growth factor receptor and integrin overexpression.
Purpose of the Study:
- To investigate the role of insulin-like growth factor-binding protein-1 (IGFBP-1) in merlin-deficient schwannoma pathogenesis.
- To elucidate the signaling pathways, including IGFBP-1, integrin β1, and focal-adhesion-kinase (FAK), involved in schwannoma cell proliferation and adhesion.
- To identify potential therapeutic targets for merlin-deficient tumors.
Main Methods:
- Utilized an in vitro model of human schwannoma.
- Employed short hairpin RNA (shRNA) knockdown, small molecule inhibitors, and recombinant IGFBP-1.
- Analyzed protein expression, activation states, subcellular localization (e.g., nuclear FAK), and pathway signaling (Src/FAK, AKT).
Main Results:
- Schwannoma cells, unlike normal Schwann cells, overexpress and release IGFBP-1.
- IGFBP-1 activates the Src/FAK pathway via β1-integrin, enhancing schwannoma cell proliferation and adhesion.
- Downregulation of phosphatase and tensin homolog (PTEN) in schwannoma cells increases anti-apoptotic AKT activity.
- Src activation was shown to trigger IGFBP-1 production, and FAK was observed in the nucleus.
Conclusions:
- The IGFBP-1/integrin β1/Src/FAK signaling axis is critical for merlin-deficient schwannoma development.
- This pathway significantly contributes to schwannoma cell proliferation and matrix adhesion.
- Targeting the IGFBP-1/integrin β1/Src/FAK pathway presents a promising therapeutic strategy for merlin-deficient tumors.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Intracellular Signaling Affects Focal Adhesions
Some...
TGF - β Signaling Pathway
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Insulin: The Receptor and Signaling Pathways
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.

